Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


Articles published in J Pathol

Retrieve available abstracts of 13 articles:
HTML format
Text format



Single Articles


    November 2018
  1. FICHE M, Scabia V, Aouad P, Battista L, et al
    Intraductal patient derived xenografts of estrogen receptor alpha positive (ER+) breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions.
    J Pathol. 2018 Nov 14. doi: 10.1002/path.5200.
    PubMed     Text format     Abstract available


  2. WESTBROOK JA, Wood SL, Cairns DA, McMahon K, et al
    Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer.
    J Pathol. 2018 Nov 14. doi: 10.1002/path.5197.
    PubMed     Text format     Abstract available


  3. MCCART REED AE, Kalita-de Croft P, Kutasovic J, Saunus JM, et al
    Recent advances in breast cancer research impacting clinical diagnostic practice.
    J Pathol. 2018 Nov 14. doi: 10.1002/path.5199.
    PubMed     Text format     Abstract available


    October 2018
  4. MCCART REED AE, Kalaw E, Nones K, Bettington M, et al
    Phenotypic and molecular dissection of Metaplastic Breast Cancer and the prognostic implications.
    J Pathol. 2018 Oct 22. doi: 10.1002/path.5184.
    PubMed     Text format     Abstract available


  5. LIU RZ, Vo TM, Jain S, Choi WS, et al
    NFIB promotes cell survival by directly suppressing p21 transcription in p53-mutated triple-negative breast cancer.
    J Pathol. 2018 Oct 22. doi: 10.1002/path.5182.
    PubMed     Text format     Abstract available


    July 2018
  6. IWABUCHI E, Miki Y, Kanai A, Miyashita M, et al
    The interaction between carcinoembryonic antigen-related cell adhesion molecule 6 and HER2 is associated with therapeutic efficacy of trastuzumab in breast cancer.
    J Pathol. 2018 Jul 29. doi: 10.1002/path.5148.
    PubMed     Text format     Abstract available


    May 2018
  7. DE GROOT JS, Ratze MAK, van Amersfoort M, Eisemann T, et al
    alphaE-catenin is a candidate tumor suppressor for the development of E-cadherin expressing lobular-type breast cancer.
    J Pathol. 2018 May 17. doi: 10.1002/path.5099.
    PubMed     Text format     Abstract available


    April 2018
  8. BARTELS S, van Luttikhuizen JL, Christgen M, Magel L, et al
    CDKN2A loss and PIK3CA mutation in myoepithelial-like metaplastic breast cancer.
    J Pathol. 2018 Apr 30. doi: 10.1002/path.5091.
    PubMed     Text format     Abstract available


    January 2018
  9. CERESER B, Jansen M, Austin E, Elia G, et al
    Analysis of clonal expansions through the normal and premalignant human breast epithelium reveals the presence of luminal stem cells.
    J Pathol. 2018;244:61-70.
    PubMed     Text format     Abstract available


    October 2017
  10. DUIVENVOORDEN HM, Rautela J, Edgington-Mitchell LE, Spurling A, et al
    Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
    J Pathol. 2017 Oct 31. doi: 10.1002/path.4990.
    PubMed     Text format     Abstract available


  11. LIU J, Ye L, Li Q, Wu X, et al
    Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.
    J Pathol. 2017 Oct 9. doi: 10.1002/path.4995.
    PubMed     Text format     Abstract available


  12. OLIEMULLER E, Kogata N, Bland P, Kriplani D, et al
    SOX11 promotes invasive growth and ductal carcinoma in situ progression.
    J Pathol. 2017;243:193-207.
    PubMed     Text format     Abstract available


    September 2017
  13. CHEN H, Liu D, Guo L, Cheng X, et al
    Chronic psychological stress promotes lung metastatic colonization of circulating breast cancer cells by decorating a pre-metastatic niche through activating beta-adrenergic signaling.
    J Pathol. 2017 Sep 22. doi: 10.1002/path.4988.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: